The risk of lung cancer drops substantially within five years of quitting, according to a new analysis of the landmark Framingham Heart Study by researchers at Vanderbilt University Medical Center.
News: Home Page Latest News
Consuelo Wilkins, MD, MSCI, has been appointed director of a new Engagement Core to support the design, implementation and governance of the national All of Us Research Program, an ambitious effort led by the National Institutes of Health (NIH) to accelerate the prevention and treatment of illness through precision medicine.
Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program, has been named a Komen Scholar for her leadership in breast cancer research. She is joined by Wayne Dornan, PhD, a patient research advocate at VICC, who will serve on the Advocates in Science Steering Committee for Susan G. Komen.
A new study by W. Kimryn Rathmell, MD, PhD, and colleagues, reveals a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs.
Theresa Sberna, MPH, has been named director of Strategy and Analytics for Vanderbilt-Ingram Cancer Center (VICC). Sberna, who previously served as associate director, has been with the Cancer Center for five years.
Derek M. Griffith has been selected for the American Association of Health Behavior Fellows Class of 2017. Griffith, who is an associate professor of Medicine, Health, and Society and founder and director of the Center for Research on Men’s Health at Vanderbilt, is being recognized for his significant contributions in the field of health behavior research.
Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.
Vanderbilt’s Pampee Young, MD, PhD, has been named chief medical officer of the American Red Cross.
Amanda Mathis went from being a patient at Vanderbilt-Ingram Cancer Center to becoming a member of the cancer center’s Board of Overseers.
My Cancer Genome (MCG), a web-based cancer information tool developed by Vanderbilt-Ingram Cancer Center investigators in 2011 and supported by GenomOncology, has launched a new clinical trial search tool that allows website visitors to search for cancer clinical trials based on disease, biomarker, phase and recruiting status.